CB1 and CB2 receptors — Drug Target

All drugs that target CB1 and CB2 receptors — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

cannabinoid · cannabinoid receptor agonist · Cannabinoid receptor agonist

Phase 3 pipeline (3)

• medical cannabis · HaEmek Medical Center, Israel · Pain management, Nausea and vomiting, Muscle spasms
  Medical cannabis exerts its effects through the body's endocannabinoid system, influencing various physiological processes.
• THC/CBD · Azienda Ospedaliera Universitaria Policlinico "G. Martino" · cannabinoid · Pain management
  THC/CBD acts on the CB1 and CB2 receptors in the brain and body.
• Single-dose of cannabis oil · Hadassah Medical Organization · Pain management, Neurology
  Cannabis oil modulates the endocannabinoid system to produce therapeutic effects.

Phase 2 pipeline (4)

• Cannabidiol 400 · Hurd,Yasmin, Ph.D. · cannabinoid receptor agonist · Neurology
  Cannabidiol 400 acts as a cannabinoid receptor agonist, modulating the endocannabinoid system to exert therapeutic effects.
• CBD, synthetic form · CannaMore Biotechs · Pain management, Anxiety disorders
  CBD, a synthetic form, interacts with the body's endocannabinoid system to produce therapeutic effects.
• Avidekel oil · Wolfson Medical Center · cannabinoid · Pain management
  Avidekel oil is a cannabis-based medication that works by interacting with the body's endocannabinoid system.
• Cannabinoids - whole plant extract · Shaare Zedek Medical Center · Cannabinoid receptor agonist · Neurology
  Activates cannabinoid receptors